Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function

Sandmark, J; Tigerstrom, A; Akerud, T; Althage, M; Antonsson, T; Blaho, S; Bodin, C; Bostrom, J; Chen, YT; Dahlen, A; Eriksson, PO; Evertsson, E; Fex, T; Fjellstrom, O; Gustafsson, D; Herslof, M; Hicks, R; Jarkvist, E; Johansson, C; Kalies, I; Svalstedt, BK; Kartberg, F; Legnehed, A; Martinsson, S; Moberg, A; Ridderstrom, M; Rosengren, B; Sabirsh, A; Thelin, A; Vinblad, J; Wellner, AU; Xu, BZ; Ostlund-Lindqvist, AM; Knecht, W

Sandmark, J (corresponding author), AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Biosci Cardiovasc, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), Lund Univ, Dept Biol & Lund Prot Prod Platform, Solvegatan 35, S-22362 Lund, Sweden.

JOURNAL OF BIOLOGICAL CHEMISTRY, 2020; 295 (15): 5136

Abstract

Increased plasma concentrations of lipoprotein(a) (Lp(a)) are associated with an increased risk for cardiovascular disease. Lp(a) is composed of apoli......

Full Text Link